Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1Classical hematology 1

Conditions

Thrombocytopenia 1Stomach Neoplasms 1Neutropenia 1Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Appendiceal Neoplasms 1

Interventions

pembrolizumab 304Carboplatin 157Nivolumab 154Cisplatin 140Cyclophosphamide 131Paclitaxel 127Magnetic Resonance Spectroscopy 99Specimen Handling 96Radiotherapy 91Gemcitabine 87Dexamethasone 83Biopsy 81Ipilimumab 78Docetaxel 76Doxorubicin 75Rituximab 69Etoposide 67atezolizumab 61Radiation 60durvalumab 60Lenalidomide 59Pemetrexed 59Taxes 57Prednisone 55Bevacizumab 54fludarabine 54olaparib 53Vincristine 50Cytarabine 49Fluorouracil 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Algorithms × 1 year × Clear all
NCT01806129 2026-06-03

EROS

Eastern Cooperative Oncology Group

Phase NA Active not recruiting
434 enrolled 9 charts
Tumor-Agnostic

Neoplasms

NCT04526886 2025-10-06

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

Dartmouth-Hitchcock Medical Center

Phase NA Completed
52 enrolled 8 charts
Classical hematologyGastrointestinal

Appendiceal Neoplasms, Esophageal Neoplasms, Neutropenia, Stomach Neoplasms, Thrombocytopenia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡